AstraZeneca Resumes Oxford Vaccine Trial In UK

Pharma giant AstraZeneca has resumed its vaccine trials for AZD1222 in UK, after the Medicines Health Regulatory in UK said it was safe to do so. In a statement, the company shared that pharma and University of Oxford could not disclose further medical information. The company is working with health authorities across the world to resume clinical trials in the respective countries so that the vaccine can be distributed equitably. 

On, September 8, the company declared that it had halted the trials after a participant exhibited symptoms of a suspected adverse reaction after vaccine inoculation.